Literature DB >> 3300586

Nephrotoxicity of common drugs used in clinical practice.

K Cooper, W M Bennett.   

Abstract

Drug-induced nephrotoxicity is an increasingly recognized complication of a wide variety of therapeutic agents. The nephrotoxicity of three of the most commonly used drug groups are reviewed in this article. They include antibiotics, radiocontrast agents, and nonsteroidal anti-inflammatory drugs. Since the clinical spectrum of drug-induced nephrotoxicity is broad, it is imperative that the clinician recognize these nephrotoxic syndromes while they are reversible with discontinuation of the offending drug.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300586

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

1.  Persistent disruption of mitochondrial homeostasis after acute kidney injury.

Authors:  Jason A Funk; Rick G Schnellmann
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

Review 2.  Drug-induced nephrotoxicity. Aetiology, clinical features and management.

Authors:  A J Hoitsma; J F Wetzels; R A Koene
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

3.  [Drug therapy for tumor pain I. Properties of non-opioids and opioids.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1994-12       Impact factor: 1.107

Review 4.  A risk-benefit appraisal of injectable NSAIDs in the management of postoperative pain.

Authors:  L S Nuutinen; J O Laitinen; T E Salomäki
Journal:  Drug Saf       Date:  1993-11       Impact factor: 5.606

Review 5.  The nephrotoxic potential of drugs and chemicals. Pharmacological basis and clinical relevance.

Authors:  G Koren
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jan-Feb

6.  Too Much of a Good Thing: Defining Antimicrobial Therapeutic Targets to Minimize Toxicity.

Authors:  Kevin J Downes; Jennifer L Goldman
Journal:  Clin Pharmacol Ther       Date:  2021-02-27       Impact factor: 6.875

7.  Safety assessment of the use of perflenapent emulsion for contrast enhancement of echocardiography and diagnostic radiology ultrasound studies.

Authors:  S C Quay; A J Eisenfeld
Journal:  Clin Cardiol       Date:  1997-10       Impact factor: 2.882

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.